Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Biofield in $365 Million China Breast Cancer Diagnostic JV

publication date: Jul 2, 2008

Biofield Corp. established a Chinese national healthcare joint venture built around its breast cancer diagnostic device. The JV joins Biofield and Carelife, which is operating through its appointed agent, China International Medical Exchange Ltd. Funded with approximately $363 million, the Carelife JV will open a China network of medical clinics, call centers and data centers for R&D. By 2012, Carelife expects to open more than 500 medical clinics in China’s major cities.  More details...

Stock Symbol: (Pink Sheets: BZEC) 



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here